Notice Title

Consent to the Distribution of New Medicines

Publication Date
14 Mar 2024

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2024-go1090
Title
View PDF
File Type and Size
PDF (35 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Ipca-Ibuprofen
Active Ingredient: Ibuprofen 200mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Ipca Pharma (NZ) Pty Limited
Manufacturer: Ipca Laboratories Limited, Silvassa, India
   
Product: Paracetamol Soft Gel Caps Extra
Active Ingredients: Caffeine 65mg
Paracetamol 500mg
Dosage Form: Soft gelatin capsule
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: XL Laboratories Pvt. Limited, Neemrana, India
   
Product: Verorab
Active Ingredient: Rabies vaccine, Wistar PM/WI 38-1503-3M 3.25IU
Dosage Form: Powder for injection with diluent
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer: Sanofi Pasteur SA, Marcy L’Etoile, France


Dated this 11th day of March 2024.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).